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ABSTRACT - Administration of fractionated doses of irradiation is part of the adjutant therapy for CNS tumours
such as craniopharyngiomas and pituitary adenomas. It can maximise cure rates or expand symptom-free period.
Among the adverse effects of radiotherapy, the induction of a new tumour within the irradiated field has been
frequently described. The precise clinical features that correlate irradiation and oncogenesis are not completely
defined, but some authors have suggested that tumors are radiation induced when they are histologically different
from the treated ones, arise in greater frequency in irradiated patients than among normal population and tend to
occur in younger people with an unusual aggressiveness. In this article, we report a case of a papillary astrocytoma
arising in a rather unusual latency period following radiotherapy for craniopharyngioma.
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Astrocitoma pilocítico pós-radioterapia para tratamento de craniofaringioma: relato de caso
RESUMO - A administração de doses fracionadas de radiação é parte do tratamento adjuvante de tumores do
sistema nervoso central como craniofaringiomas ou adenomas hipofisários. A radioterapia pode aumentar as
chances de cura ou expandir o período livre de sintomas. Dentre seus efeitos adversos, é conhecida a possibilidade
de aparecimento de novo tumor na região irradiada. Os critérios que definem se um novo tumor é de fato induzido
por radiação ainda não são completamente definidos. Adimite-se, no entanto, que se o novo tumor é
histologicamente diferente do primeiro, aparece em indivíduos mais jovens e é mais agressivo que o habitual,
provavelmente sua origem é devida à oncogênese da irradiação. Descrevemos um caso de astrocitoma pilocítico
possivelmente induzido por radioterapia, com surgimento em tempo de latência inesperadamente curto.
PALAVRAS-CHAVE: astrocitoma pilocítico, efeitos adversos de radioterapia, oncogênese.
Conventional radiation therapy is commonly applied as adjutant treatment for central nervous system
(CNS) tumours1. Lesions that continue to growth despite surgical ablation or are not amenable to complete
resection tend to recur lately when submitted to irradiation2. Among benign CNS tumours, pituitary
adenomas and craniopharyngiomas are those for which standard fractionated radiation or stereotatic
radiosurgery is usually performed3. For these lesions adjunctive radiation has a clear-cut positive effect
maximising cure rates and adjourning the reappearance of symptoms. Radiation therapy can produce
side effects such as tissue damage4-11 and neoplastic transformation1,12 in the irradiated field. Tumour
development after radiotherapy is constantly described as an unusual but invariably serious medium
term complication of irradiation13,14. For patients undergoing sellar irradiation, gliomas are the most
frequent tumours, usually presented with marked aggressive behaviour and young age of onset1,11.
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In this article we report a case of radiation induced pilocytic astrocytoma with clinical
aggressive behaviour developed in a rather unusual period (6 months) after radiotherapy for a
craniopharyngioma.
CASE
A 36-year-old previously healthy woman was referred in 1996 to a neurosurgical consult by her
endocrinologist with a 18-month history of symptoms of panhypopytuitarism and amenorrhoea. A skull roentgen
showed a normal sellar region, while an MRI depicted a cystic supraselar lesion. In July of 1996, the patient
underwent a right temporo-fronto-sphenoidal craniotomy with complete resection of the tumour. A histological
examination of the specimen showed a suprasellar papillary squamous epithelium (Fig 1). The definitive diagnosis
was papillary craniopharyngioma due to the complexity of the epithelium and the absence of skin adnexae and
keratin, expected in dermoid and epidermoid cysts. One month after surgery the patient started radiation therapy
with 5860cGy, with daily fractions of 180cGy. Six months after the beginning of radiotherapy, the patient presented
a progressive bitemporal hemianopia and a new MRI presented a 1.0 x 0.9 cm supra sellar lesion infiltrating the
optic chiasm. In June of 1997 the patient underwent a new surgical procedure with partial tumour resection.
Histological analysis showed a lesion with conspicuous elongated and citologically bland cells intermixed with
Rosenthal fibers (Fig 2). Due to its marked cellularity and the presence of the Rosenthal fibers, pylocitic astrocytoma
was the definitive diagnosis, opposed to gliosis. The patient quickly developed complete blindness and diabetes
insipidus after surgery and died 5 months later, reinforcing the diagnosis of a second tumour.
DISCUSSION
Tissue damage in the irradiated field yield side effects that in the brain and CNS may include
optic neuritis7,10, vasculopathy6,11, cognitive and psychological disturbances4,8 and hypothalamic
insufficiency5,9. Moreover, due to base pair disruption and deoxyribonucleic acid (DNA) strand
alteration, irradiation can produce neoplastic transformation12. Tumour development within the
irradiated field constitutes a known consequence with very detrimental outcome13,14.
The most common intracranial nonglial CNS tumours induced by radiation are meningiomas
and sarcomas12,15-17. After sellar irradiation gliomas are the most frequent glial tumours11,18. For patients
undergoing sellar irradiation, the relative risk for developing a glioma is approximately 8 bigger
Fig 1. Cystic craniopharyngioma: rounded complex squamous epithelium with loose center. H&E., 400x.
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than in the normal19. Tumour development after radiotherapy is considered radiation induced when
some criteria are met. These include: the new lesion arises within the field of radiation; it is
histologically different from the first tumour; it appears after a latency period that reasonably permits
a secondary tumour development and there are not other conditions predisposing tumorigenesis20.
Tumours evolving after sellar irradiation are generally reported by sporadical case
descriptions11. Despite the relative abundance of tumour neogenesis examples, the appearance of a
second and unrelated CNS neoplasm after brain irradiation for a primary lesion is not the rule.
However, the increased risk of developing a new tumour after irradiation and the peculiar settings
presented by these second lesions argue against a simple coincident association21,22. In a cohort
study performed in 1992 with 334 patients undergoing 4500 cGy sellar irradiation for treatment of
pituitary lesions, the relative risk of a new tumour development was significantly increased (7.92
times) compared to the one bore by the normal non-irradiated population19. Large series have shown
that skull low dose irradiation (350-425cGy) for pediatric treatment of Tinea capitis increases the
relative risk for developing a brain tumour by 2.6 times18. Likewise, malignant CNS tumours have
been witnessed to evolve in animal models submitted to brain irradiation with proton or x-ray in a
much higher frequency than in non-irradiated animals13,23-25.
The use of fractionated doses of radiotherapy associated with spatial strategies to avoid
excessive exposure of single brain territories or paths have been applied in order to minimise side
effects and neoplastic transformation originated by radiation7,26. It is not yet known whether a clear-
cut dose response curve may be used regarding new tumour developing, but it seems that fractionated
radiation is responsible to lessen the appearance of side effects7,27. The use of 50 to 55 cGy in 25
sessions is capable of controlling primary tumour growth with a somewhat small level of
complications11,12,28.
Tumours appearing after irradiation usually differ from their “spontaneous” counterparts mainly
because of the age of onset and aggressiveness observed21,22. The average range for glioma appearance
in the normal population is the sixth decade. Gliomas appearing before or in the lower extreme of
this range are generally expected to have a benign course.
Fig 2. Pilocytic astrocytoma with astrocytes showing elongated nuclei and fibrillary cytoplasm, intermixed
with Rosenthal fibers. H&E., 400x.
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Comprehensive analysis of new cases of glioma after radiation for craniopharyngioma depict
that its average age of onset is roughly 27 yr., much younger than the age of onset of glial tumours in
the normal population or even after radiotherapy for pituitary adenomas, what is explained by the
younger presentation of craniopharyngiomas1. Opposed to what should be expected in young patients
also shows a rather different histological behaviour, with increased frequency of more aggressive
patterns, comprising mainly grade III and IV gliomas.
We observed that in 8 cases of gliomas after radiotherapy for craniopharyngiomas (Table),
the average latency period between irradiation and symptoms due to new tumour was 12.1 yr., with
the smallest latency period reported of 5 years .
Conclusion
In this article we report an unusual case with unfavourable clinical outcome of a patient with
craniopharyngioma who underwent surgical and irradiation treatment. As confirmed by post-surgical
histological analysis, there was not recurrence of the first tumour but appearance of what could have
been considered post-surgical gliosis or another tumour35. Since the patient was submitted to radiation
therapy and had a fast unfavourable clinical course, we accepted that it was indeed a totally new
lesion with very aggressive behaviour. We also considered that the histological feature of the second
lesion was apparently benign, corresponding to a low-grade glioma. However, due to the rapid
clinical deterioration, we considered it to be in fact a dynamic and rapid changing tumour, evolving
quickly to aggressiveness. This hypothesis, unfortunately, could not have been confirmed by autopsy,
which was not desired by the patient’s relatives. Nonetheless, the data presented above strong suggests
that the new lesion had a very aggressive and rapid changing status, based upon clinical settings.
The new tumour reported fulfils every variable suggested by the criteria above in order to be
considered induced by radiation. However, it arised in a rather unusual latency period after
radiotherapy (6 months). We therefore want to draw attention to irradiated induced tumours that
may be formed in different settings, considering that it could have been originated by radiation,
despite its rapid appearance.
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